Log in
APRINOIA Therapeutics
Contact
Links
View in org chart
Mark S. Shearman
CEO
Bradford A. Navia
Chief Medical Officer
Masaomi Miyamoto
EVP of R&D & Operations
Tzu-Chen Yen
General Manager
Lili Zhang
SVP, Head of Preclinical Development
+ 4 more
December, 2021 - present
